Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

18F-FDG-PET/CT to Detect Pathological Complete Response After Neoadjuvant Treatment in Patients with Cancer of the Esophagus or Gastroesophageal Junction:Accuracy and Long-Term Implications

Autor: van der Aa, D. C., Gisbertz, S. S., Anderegg, M. C. J., Lagarde, S. M., Klaassen, R., Meijer, S. L., van Dieren, S., Hulshof, Mccm, Bergman, Jjghm, Bennink, R. J., van Laarhoven, H. W. M., van Berge Henegouwen, M. I.

Publikováno v: van der Aa, D C, Gisbertz, S S, Anderegg, M C J, Lagarde, S M, Klaassen, R, Meijer, S L, van Dieren, S, Hulshof, M, Bergman, J, Bennink, R J, van Laarhoven, H W M & van Berge Henegouwen, M I 2023, ' 18F-FDG-PET/CT to Detect Pathological Complete Response After Neoadjuvant Treatment in Patients with Cancer of the Esophagus or Gastroesophageal Junction : Accuracy and Long-Term Implications ', Journal of gastrointestinal cancer . https://doi.org/10.1007/s12029-023-00951-2

Purpose : The curative strategy for patients with esophageal cancer without distant metastases consists of esophagectomy with preceding chemo(radio)therapy (CRT). In 10–40% of patients treated with CRT, no viable tumor is detectable in the resectio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10172::1791015c9d766a4b815dcf705ed2da5d
https://research.vumc.nl/en/publications/1b9aeaf6-efa5-4522-adcf-8c5bd8a67b72

Additional file 1 of FOXO transcriptional activity is associated with response to chemoradiation in EAC

Autor: Creemers, A., van der Zalm, A. P., van de Stolpe, A., Holtzer, L., Stoffels, M., Hooijer, G. K. J., Ebbing, E. A., van Ooijen, H., van Brussel, A. G. C., Aussems-Custers, E. M. G., van Berge Henegouwen, M. I., Hulshof, M. C. C. M., Bergman, J. J. G. H. M., Meijer, S. L., Bijlsma, M. F., van Laarhoven, H. W. M.

Additional file 1: Figure S1. Poor responder phenotype in patient samples. A Pathway signal transduction activity of six key signal transduction pathways was measured in the resectable disease cohort (i). Pre-treatment biopsy pathway activity scores

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48ecaec57f6910beca0af6208061f860

Additional file 5 of FOXO transcriptional activity is associated with response to chemoradiation in EAC

Autor: Creemers, A., van der Zalm, A. P., van de Stolpe, A., Holtzer, L., Stoffels, M., Hooijer, G. K. J., Ebbing, E. A., van Ooijen, H., van Brussel, A. G. C., Aussems-Custers, E. M. G., van Berge Henegouwen, M. I., Hulshof, M. C. C. M., Bergman, J. J. G. H. M., Meijer, S. L., Bijlsma, M. F., van Laarhoven, H. W. M.

Additional file 5: Table S1. Characteristics of the five established patient derived cell lines. Table S2. FDA approved PI3K inhibitors tested in this study. Table S3 Western blot antibodies used in this study.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9691a78f8582b6ea5fbf901ba6066fb3

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.